Seehra Jasbir bought KROS
September 3, 2025 · Form 4 insider transaction
Seehra Jasbir bought 90,500 shares of Keros Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
90,500
Price
$0.00
Total value
N/A
InsiderSeehra Jasbir
RoleOfficer, Director
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateSeptember 3, 2025
Filing dateSeptember 5, 2025
Shares owned after392,723
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents a restricted stock unit ("RSU") award. The RSUs vest as follows: 25% of the RSUs shall vest on each of February 18, 2026, February 18, 2027, February 18, 2028 and February 18, 2029, in each case, subject to the Reporting Person continuing to provide service through each such date.